Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Hey Chong"'
Autor:
Robert J. Wood, Edmond S. Chan, Hey Chong, Paul J. Dowling, Allan Stillerman, Lynda C. Schneider, Stanley M. Fineman, Amarijit Cheema, Hugh A. Sampson, Edwin H. Kim, Timothée Bois, Todd D. Green, Ned Rupp, Terri F. Brown-Whitehorn, Sara Anvari, Dareen Siri, Roxanne C. Oriel, Jacqueline A. Pongracic, Sayantani B. Sindher, William E. Berger, Hemalini Mehta, Gordon Sussman, Erika G. Gonzalez-Reyes, Dianne E. Campbell, William H. Yang, Amy M. Scurlock, Sharon Chinthrajah, J. Andrew Bird, Lawrence Sher, Andrew J. MacGinnitie, Remi Gagnon, David Fleischer, Wayne G. Shreffler, Philippe Bégin, Bruce J. Lanser, Daniel Petroni
Publikováno v:
The journal of allergy and clinical immunology. In practice. 10(7)
Background Treatment options for peanut allergy are limited. In previous clinical trials, epicutaneous immunotherapy with a patch containing 250-μg peanut protein (Viaskin™ Peanut 250 μg [VP250]) was well tolerated and statistically superior to p
Autor:
Hey Chong, Antonella Muraro, Caroline Nilsson, Julie Wang, Jonathan Matz, Tara F. Carr, Andrea Vereda, Stephanie A. Leonard, Douglas T Johnston, Katharina Blumchen, Moshe Ben-Shoshan, Stanley Fineman, Frank C Hampel, Montserrat Fernandez-Rivas, Michael J Welch, José Manuel Zubeldia, Jay M. Portnoy, Carsten Bindslev-Jensen, Rima Rachid, Leon Greos, Vibha Sharma, Brian P. Vickery, Marina Tsoumani, Dareen Siri, Edwin H. Kim, Lyndon E Mansfield, A. Wesley Burks, J. Andrew Bird, Daniel C. Adelman, Ellen Sher, Robert A. Wood, Thomas B. Casale, Stephen A. Tilles, Annette Marcantonio, Hugh H Windom, Hanneke N G Oude Elberink, Stefan Zielen, Hemant P Sharma, Wayne G. Shreffler, Bruce J. Lanser, Amarjit Cheema, Ned Rupp, Stephen B Fritz, Stacie M. Jones, Allan Stillerman, Gordon Sussman, Frederick E Leickly, Stephen G Dilly, W. Carr, Jay A. Lieberman, Pooja Varshney, David Fleischer, Kirsten Beyer, William H. Yang, Jacqueline A. Pongracic, Morna J. Dorsey, George Du Toit, Jason A. Ohayon, Aikaterini Anagnostou, M Dolores Ibáñez, David K Jeong, Amal Assa'ad, Jonathan O'b Hourihane, Rita Kachru, Anthony E.J. Dubois, Christina E. Ciaccio, Rezi Zawadzki, Sharon Chinthrajah, Lawrence Sher, Georgiana M Sanders, Jonathan M. Spergel
Publikováno v:
Vickery, B P, Vereda, A, Casale, T B, Beyer, K, Du Toit, G, Hourihane, J O, Jones, S M, Shreffler, W G, Marcantonio, A, Bindslev-Jensen, C & PALISADE Group of Clinical Investigators 2018, ' AR101 Oral Immunotherapy for Peanut Allergy ', The New England Journal of Medicine, vol. 379, no. 21, pp. 1991-2001 . https://doi.org/10.1056/NEJMoa1812856
New England Journal of Medicine, 379(21), 1991-2001. MASSACHUSETTS MEDICAL SOC
New England Journal of Medicine, 379(21), 1991-2001. MASSACHUSETTS MEDICAL SOC
BACKGROUND: Peanut allergy, for which there are no approved treatment options, affects patients who are at risk for unpredictable and occasionally life-threatening allergic reactions.METHODS: In a phase 3 trial, we screened participants 4 to 55 years
Autor:
Amal Assa'ad, Edwin H. Kim, Todd D. Green, Jacqueline A. Pongracic, Hey Chong, Stephanie A. Leonard, Dianne E. Campbell, Daniel Petroni, Carla M. Davis, Edmond S. Chan, Pete Smith, Jacques Hébert, Lynda C. Schneider, Philippe Bégin, Jonathan O'b Hourihane, Kirsten Beyer, J. Andrew Bird, David Fleischer, Lars Lange, Wayne G. Shreffler, William H. Yang, Gordon Sussman, Bruce J. Lanser, Susan L. Prescott, Anna Nowak-Wegrzyn, Terri F. Brown-Whitehorn, Amarjit Cheema, Stacie M. Jones, Aideen Byrne, R. Sharon Chinthrajah, Robert J. Wood, Romain Lambert, Matthew Greenhawt
Publikováno v:
JAMA. 321:946
IMPORTANCE: There are currently no approved treatments for peanut allergy. OBJECTIVE: To assess the efficacy and adverse events of epicutaneous immunotherapy with a peanut patch among peanut-allergic children. DESIGN, SETTING, AND PARTICIPANTS: Phase